{"transactions":[{"id":948747,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-01-06T21:10:05.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1962,"derivative":{"exercise_price":772.76,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":1962},"source":{"system":"sec-edgar","filing":"0001174475-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000117447526000002/edgardoc.xml","form_type":"4"}},{"id":948746,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:10:05.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1703,"source":{"system":"sec-edgar","filing":"0001174475-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000117447526000002/edgardoc.xml","form_type":"4"}},{"id":1312106,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-01-06T21:05:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":1958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1958,"derivative":{"exercise_price":719.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":1958},"source":{"system":"sec-edgar","filing":"0001968202-25-000003","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000003/edgardoc.xml","form_type":"4"}},{"id":1312105,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T21:05:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1548,"source":{"system":"sec-edgar","filing":"0001968202-25-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000003/edgardoc.xml","form_type":"4"}},{"id":1478030,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:01:48.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":false,"shares":1535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":625.6,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":1535},"source":{"system":"sec-edgar","filing":"0001968202-24-000102","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000102/edgardoc.xml","form_type":"4"}},{"id":1478029,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T20:01:48.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":1535,"price":1040,"value":1596400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024."}],"balance_after":1382,"source":{"system":"sec-edgar","filing":"0001968202-24-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000102/edgardoc.xml","form_type":"4"}},{"id":1478028,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T20:01:48.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":true,"shares":1535,"price":625.6,"value":960296.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024."}],"balance_after":2917,"source":{"system":"sec-edgar","filing":"0001968202-24-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000102/edgardoc.xml","form_type":"4"}},{"id":1499656,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-05-29T20:01:07.000Z","date":"2024-05-28","kind":"exercise","planned":true,"acquired":false,"shares":1172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":1535,"derivative":{"exercise_price":625.6,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":1172},"source":{"system":"sec-edgar","filing":"0001104659-24-066045","document":"tm2414958-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000110465924066045/tm2414958-1_4seq1.xml","form_type":"4"}},{"id":1499655,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T20:01:07.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":1172,"price":974.86,"value":1142535.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024."}],"balance_after":1382,"source":{"system":"sec-edgar","filing":"0001104659-24-066045","document":"tm2414958-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000110465924066045/tm2414958-1_4seq1.xml","form_type":"4"}},{"id":1499654,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T20:01:07.000Z","date":"2024-05-28","kind":"exercise","planned":true,"acquired":true,"shares":1172,"price":625.6,"value":733203.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024."}],"balance_after":2554,"source":{"system":"sec-edgar","filing":"0001104659-24-066045","document":"tm2414958-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000110465924066045/tm2414958-1_4seq1.xml","form_type":"4"}},{"id":1689438,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:06:09.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":1607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1607,"derivative":{"exercise_price":888.34,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":1607},"source":{"system":"sec-edgar","filing":"0001968202-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000022/edgardoc.xml","form_type":"4"}},{"id":1689437,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:06:09.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1382,"source":{"system":"sec-edgar","filing":"0001968202-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000022/edgardoc.xml","form_type":"4"}},{"id":1698255,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-12-29T21:06:46.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":false,"shares":2049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":482.68,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":2049},"source":{"system":"sec-edgar","filing":"0001883850-23-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000109/edgardoc.xml","form_type":"4"}},{"id":1698254,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-29T21:06:46.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":2049,"price":898,"value":1840002.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 24, 2023."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001883850-23-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000109/edgardoc.xml","form_type":"4"}},{"id":1698253,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-29T21:06:46.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":true,"shares":2049,"price":482.68,"value":989011.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 24, 2023."}],"balance_after":3296,"source":{"system":"sec-edgar","filing":"0001883850-23-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000109/edgardoc.xml","form_type":"4"}},{"id":1915153,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-04-24T20:05:04.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":false,"shares":3070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 22, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":520.01,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":3070},"source":{"system":"sec-edgar","filing":"0001968202-23-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000009/edgardoc.xml","form_type":"4"}},{"id":1915152,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T20:05:04.000Z","date":"2023-04-21","kind":"sale","planned":true,"acquired":false,"shares":3070,"price":798.42,"value":2451149.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 22, 2023."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001968202-23-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000009/edgardoc.xml","form_type":"4"}},{"id":1915151,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T20:05:04.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":true,"shares":3070,"price":520.01,"value":1596430.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 22, 2023."}],"balance_after":4317,"source":{"system":"sec-edgar","filing":"0001968202-23-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000009/edgardoc.xml","form_type":"4"}},{"id":2027187,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-02-08T21:15:58.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":3071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":3070,"derivative":{"exercise_price":520.01,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":3071},"source":{"system":"sec-edgar","filing":"0001883850-23-000045","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000045/edgardoc.xml","form_type":"4"}},{"id":2027186,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-08T21:15:58.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":500,"price":797,"value":398500.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":6162,"source":{"system":"sec-edgar","filing":"0001883850-23-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000045/edgardoc.xml","form_type":"4"}},{"id":2027185,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-08T21:15:58.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":3071,"price":798,"value":2450658.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001883850-23-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000045/edgardoc.xml","form_type":"4"}},{"id":2027184,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-08T21:15:58.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":3071,"price":520.01,"value":1596950.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":4318,"source":{"system":"sec-edgar","filing":"0001883850-23-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000045/edgardoc.xml","form_type":"4"}},{"id":2042816,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-30T21:11:48.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":6141,"derivative":{"exercise_price":520.01,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001883850-23-000027","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000027/edgardoc.xml","form_type":"4"}},{"id":2042815,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T21:11:48.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":1,"price":747,"value":747.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001883850-23-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000027/edgardoc.xml","form_type":"4"}},{"id":2042814,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T21:11:48.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":1,"price":520.01,"value":520.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1248,"source":{"system":"sec-edgar","filing":"0001883850-23-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000027/edgardoc.xml","form_type":"4"}},{"id":2058007,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-10T21:03:48.000Z","date":"2023-01-06","kind":"exercise","acquired":false,"shares":3070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":6142,"derivative":{"exercise_price":520.01,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":3070},"source":{"system":"sec-edgar","filing":"0001883850-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000025/edgardoc.xml","form_type":"4"}},{"id":2058006,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-10T21:03:48.000Z","date":"2023-01-06","kind":"sale","acquired":false,"shares":3070,"price":747.14,"value":2293719.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 3,070 shares of Company stock on January 6, 2023 at prices ranging from $747.00 to $747.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 6, 2023 at each separate price."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001883850-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000025/edgardoc.xml","form_type":"4"}},{"id":2058005,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-10T21:03:48.000Z","date":"2023-01-06","kind":"exercise","acquired":true,"shares":3070,"price":520.01,"value":1596430.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":4317,"source":{"system":"sec-edgar","filing":"0001883850-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000025/edgardoc.xml","form_type":"4"}},{"id":2064243,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-05T21:21:20.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1929,"derivative":{"exercise_price":725.89,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":1929},"source":{"system":"sec-edgar","filing":"0001883850-23-000019","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000019/edgardoc.xml","form_type":"4"}},{"id":2064242,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:21:20.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001883850-23-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000019/edgardoc.xml","form_type":"4"}},{"id":2120488,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":1564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":2049,"derivative":{"exercise_price":482.68,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":1564},"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120487,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":374.12,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":2431},"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120486,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":500,"price":748.49,"value":374245.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":6662,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120485,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":200,"price":768.11,"value":153622.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $768.08 to $768.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":1082,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120484,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":201,"price":767.25,"value":154217.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 201 shares of Company stock on November 8, 2022 at prices ranging from $767.09 to $767.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":1282,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120483,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":201,"price":766.74,"value":154114.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 201 shares of Company stock on November 8, 2022 at prices ranging from $766.59 to $766.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":1483,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120482,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":100,"price":765.19,"value":76519.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1684,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120481,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":200,"price":764.23,"value":152846.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $764.10 to $764.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":1784,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120480,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":200,"price":763.19,"value":152638.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $763.18 to $763.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":1984,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120479,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":100,"price":761.53,"value":76153.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":2184,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120478,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":200,"price":760.7,"value":152140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $760.50 to $760.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":2284,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120477,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":200,"price":754.7,"value":150940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $754.68 to $754.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":2484,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120476,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":300,"price":753.66,"value":226098.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 300 shares of Company stock on November 8, 2022 at prices ranging from $753.15 to $753.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":2684,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120475,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":203,"price":752.14,"value":152684.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 203 shares of Company stock on November 8, 2022 at prices ranging from $752.02 to $752.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":2984,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120474,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":126,"price":751.23,"value":94654.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 126 shares of Company stock on November 8, 2022 at prices ranging from $751.10 to $751.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":3187,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120473,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"exercise","acquired":true,"shares":1564,"price":482.68,"value":754911.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":3313,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120472,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":1764,"price":748.48,"value":1320318.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 1,764 shares of Company stock on November 8, 2022 at prices ranging from $748.24 to $748.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price."}],"balance_after":1749,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2120471,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:00:34.000Z","date":"2022-11-08","kind":"exercise","acquired":true,"shares":2431,"price":374.12,"value":909485.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":3513,"source":{"system":"sec-edgar","filing":"0001883850-22-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000094/edgardoc.xml","form_type":"4"}},{"id":2313522,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-31T20:04:48.000Z","date":"2022-03-30","kind":"exercise","acquired":false,"shares":408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":2431,"derivative":{"exercise_price":374.12,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":408},"source":{"system":"sec-edgar","filing":"0001708138-22-000030","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000030/edgardoc.xml","form_type":"4"}},{"id":2313521,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-31T20:04:48.000Z","date":"2022-03-29","kind":"exercise","acquired":false,"shares":1522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":2839,"derivative":{"exercise_price":374.12,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":1522},"source":{"system":"sec-edgar","filing":"0001708138-22-000030","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000030/edgardoc.xml","form_type":"4"}},{"id":2313520,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-31T20:04:48.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":408,"price":699,"value":285192.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1082,"source":{"system":"sec-edgar","filing":"0001708138-22-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000030/edgardoc.xml","form_type":"4"}},{"id":2313519,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-31T20:04:48.000Z","date":"2022-03-30","kind":"exercise","acquired":true,"shares":408,"price":374.12,"value":152640.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1490,"source":{"system":"sec-edgar","filing":"0001708138-22-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000030/edgardoc.xml","form_type":"4"}},{"id":2313518,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-31T20:04:48.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":1522,"price":699,"value":1063878.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1082,"source":{"system":"sec-edgar","filing":"0001708138-22-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000030/edgardoc.xml","form_type":"4"}},{"id":2313517,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-31T20:04:48.000Z","date":"2022-03-29","kind":"exercise","acquired":true,"shares":1522,"price":374.12,"value":569410.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":2604,"source":{"system":"sec-edgar","filing":"0001708138-22-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000030/edgardoc.xml","form_type":"4"}},{"id":2376231,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T21:07:06.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":500,"price":608.68,"value":304340.0,"ownership":{"direct":false,"nature":"by Trust"},"balance_after":7162,"source":{"system":"sec-edgar","filing":"0001708138-22-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000017/edgardoc.xml","form_type":"4"}},{"id":2445913,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-05T21:18:58.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":2707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":2707,"derivative":{"exercise_price":625.6,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":2707},"source":{"system":"sec-edgar","filing":"0001708138-22-000005","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000005/edgardoc.xml","form_type":"4"}},{"id":2445912,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:18:58.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1082,"source":{"system":"sec-edgar","filing":"0001708138-22-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000005/edgardoc.xml","form_type":"4"}},{"id":2570112,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":3612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":3612},"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570111,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":3613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":3612,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":3613},"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570110,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":2479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":380.95,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2479},"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570109,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":62,"price":652.26,"value":40440.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570108,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":3712,"price":651.1,"value":2416883.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 3,712 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":953,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570107,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1800,"price":650.4,"value":1170720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 13, 2021 at prices ranging from $650.19 to $650.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":4665,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570106,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":838,"price":649.46,"value":544247.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 838 shares of Company stock on September 13, 2021 at prices ranging from $649.00 to $649.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":6465,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570105,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":962,"price":648.48,"value":623837.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 962 shares of Company stock on September 13, 2021 at prices ranging from $648.30 to $648.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":7303,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570104,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":151,"price":647.58,"value":97784.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 151 shares of Company stock on September 13, 2021 at prices ranging from $647.42 to $647.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":8265,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570103,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":646.28,"value":64628.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":8416,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570102,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":645.66,"value":64566.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":8516,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570101,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":644.89,"value":64489.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":8616,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570100,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":643.49,"value":64349.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":8716,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570099,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":400,"price":642.62,"value":257048.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 400 shares of Company stock on September 13, 2021 at prices ranging from $642.36 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":8816,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570098,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":641.12,"value":64112.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":9216,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570097,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":640.77,"value":64077.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":9316,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570096,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":203,"price":639.2,"value":129757.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 203 shares of Company stock on September 13, 2021 at prices ranging from $639.09 to $639.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":9416,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570095,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":676,"price":638.64,"value":431720.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 676 shares of Company stock on September 13, 2021 at prices ranging from $638.16 to $638.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":9619,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570094,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":200,"price":637.29,"value":127458.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on September 13, 2021 at prices ranging from $637.20 to $637.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price."}],"balance_after":10295,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570093,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":636.74,"value":63674.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":10495,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570092,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":3612,"price":413.33,"value":1492947.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":10595,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570091,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":3613,"price":413.33,"value":1493361.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":6983,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2570090,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:54.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":2479,"price":380.95,"value":944375.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":3370,"source":{"system":"sec-edgar","filing":"0001708138-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000082/edgardoc.xml","form_type":"4"}},{"id":2609205,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T21:00:54.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":1687,"price":612.38,"value":1033085.06,"ownership":{"direct":false,"nature":"by Trust"},"balance_after":7662,"source":{"system":"sec-edgar","filing":"0001237899-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000012/edgardoc.xml","form_type":"4"}},{"id":2654143,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-28T20:01:27.000Z","date":"2021-06-25","kind":"exercise","acquired":false,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":371.4,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":2084},"source":{"system":"sec-edgar","filing":"0001708138-21-000028","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000028/edgardoc.xml","form_type":"4"}},{"id":2654142,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T20:01:27.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":2084,"price":549,"value":1144116.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0001708138-21-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000028/edgardoc.xml","form_type":"4"}},{"id":2654141,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T20:01:27.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":2084,"price":371.4,"value":773997.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":2975,"source":{"system":"sec-edgar","filing":"0001708138-21-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000028/edgardoc.xml","form_type":"4"}},{"id":2667100,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-16T20:02:26.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":2084,"derivative":{"exercise_price":371.4,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001708138-21-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000023/edgardoc.xml","form_type":"4"}},{"id":2667099,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T20:02:26.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":1700,"price":525,"value":892500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0001708138-21-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000023/edgardoc.xml","form_type":"4"}},{"id":2667098,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T20:02:26.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":1700,"price":371.4,"value":631380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":2591,"source":{"system":"sec-edgar","filing":"0001708138-21-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000023/edgardoc.xml","form_type":"4"}},{"id":2894077,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-01-27T21:06:29.000Z","date":"2021-01-25","kind":"exercise","acquired":false,"shares":2480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":2479,"derivative":{"exercise_price":380.95,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2480},"source":{"system":"sec-edgar","filing":"0001708138-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000012/edgardoc.xml","form_type":"4"}},{"id":2894076,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-27T21:06:29.000Z","date":"2021-01-25","kind":"sale","acquired":false,"shares":2480,"price":554.32,"value":1374713.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0001708138-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000012/edgardoc.xml","form_type":"4"}},{"id":2894075,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-27T21:06:29.000Z","date":"2021-01-25","kind":"exercise","acquired":true,"shares":2480,"price":380.95,"value":944756.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":3371,"source":{"system":"sec-edgar","filing":"0001708138-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000012/edgardoc.xml","form_type":"4"}},{"id":2923398,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-01-05T21:53:53.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":3613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":3613,"derivative":{"exercise_price":482.68,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":3613},"source":{"system":"sec-edgar","filing":"0001237899-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000004/edgardoc.xml","form_type":"4"}},{"id":2923397,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:53:53.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0001237899-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000004/edgardoc.xml","form_type":"4"}},{"id":3024173,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-09-23T20:01:19.000Z","date":"2020-09-22","kind":"exercise","acquired":false,"shares":2480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":4959,"derivative":{"exercise_price":380.95,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2480},"source":{"system":"sec-edgar","filing":"0001708138-20-000106","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000106/edgardoc.xml","form_type":"4"}},{"id":3024172,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-09-23T20:01:19.000Z","date":"2020-09-22","kind":"exercise","acquired":false,"shares":2610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":376.69,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":2610},"source":{"system":"sec-edgar","filing":"0001708138-20-000106","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000106/edgardoc.xml","form_type":"4"}},{"id":3024171,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:01:19.000Z","date":"2020-09-22","kind":"sale","acquired":false,"shares":1000,"price":552.36,"value":552360.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":9349,"source":{"system":"sec-edgar","filing":"0001708138-20-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000106/edgardoc.xml","form_type":"4"}},{"id":3024170,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:01:19.000Z","date":"2020-05-13","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"balance_after":10349,"source":{"system":"sec-edgar","filing":"0001708138-20-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000106/edgardoc.xml","form_type":"4"}},{"id":3024169,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:01:19.000Z","date":"2020-09-22","kind":"sale","acquired":false,"shares":5090,"price":552.36,"value":2811512.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":643,"source":{"system":"sec-edgar","filing":"0001708138-20-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000106/edgardoc.xml","form_type":"4"}},{"id":3024168,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:01:19.000Z","date":"2020-09-22","kind":"exercise","acquired":true,"shares":2610,"price":376.69,"value":983160.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":5733,"source":{"system":"sec-edgar","filing":"0001708138-20-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000106/edgardoc.xml","form_type":"4"}},{"id":3024167,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:01:19.000Z","date":"2020-09-22","kind":"exercise","acquired":true,"shares":2480,"price":380.95,"value":944756.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":3123,"source":{"system":"sec-edgar","filing":"0001708138-20-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000106/edgardoc.xml","form_type":"4"}},{"id":3093762,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":16877,"kind":"person","name":"BROWN MICHAEL S","position":1,"cik":"0001174475","reported_name":"BROWN MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-02T20:02:20.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":3613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":7225,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":3613},"source":{"system":"sec-edgar","filing":"0001708138-20-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000082/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-07-02T20:02:20.000000Z,3093762"}